Skip to main content
Caplight Logo









SpyGlass Pharma

SpyGlass Pharma

Public
Aliso Viejo, CaliforniaHealthcare/Wellnesshttps://spyglasspharma.com/

SpyGlass Pharma is now publicly traded

The data on this page reflects SpyGlass Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Feb 9, 2026

Last Round

Series D

Jun 2, 2025

Est. Valuation at Exit

$355M

Total Funding Raised

$371M

Company Overview

SpyGlass Pharma is a biopharmaceutical company that develops sustained drug delivery systems for the treatment of chronic ophthalmic conditions.

Sector

Healthcare/Wellness

Verticals

HealthTech, Life Sciences

AI Layer

Non-AI

Keywords

glaucoma treatmentdrug-delivery implantintraocular lenssustained-release technologyBIM-IOLocular drug deliverycataract surgerydrug-eluting implantophthalmology devicecurrent procedural terminologyCPTmedtechbiotechambulatory surgery centerASC

SpyGlass Pharma Comparables

Compare SpyGlass Pharma with similar companies based on industry and business-model similarity.

SpyGlass Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glaukos Corporation
85%
PolyActiva
78%
Ocular Therapeutix Inc
78%

SpyGlass Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 9, 2026
Series DJun 2, 2025
Series CJul 10, 2023
Series BJan 7, 2021
Series AMay 1, 2019

Key People

Founding team and executive leadership

Glenn Sussman

Co-Founder And CTO

Founding Team

Jean-Frederic Viret

Chief Financial Officer

Executive Team

SpyGlass Pharma Investors

Notable investors and investment history

SpyGlass Pharma investors
InvestorRounds
JefferiesIPO
RA Capital AdvisorsSeries C, Series D
RA Capital ManagementIPO, Series D, Series C
Vertex Ventures HCIPO, Series C, Series D
New Enterprise Associates (NEA)Series B, IPO, Series D, Series C, Series A
Gilde HealthcareIPO, Series D
Vensana CapitalIPO, Series C, Series B, Series D

SpyGlass Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SpyGlass Pharma Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersAliso Viejo, California
Employee Range76
Year Founded2019
Last FundingJun 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?